| Announce Date | 02/06/2026 |
| EPS Normalized Actual | $3.06 (Beat by $0.13) |
| EPS GAAP Actual | $3.06 (Beat by $0.13) |
| Revenue Actual | $1.1417B |
| Revenue Surprise | Beat by $1141.7M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.41906 |
| EPS GAAP Estimate | $2.41906 |
| Revenue Estimate | $0.563157681B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 12.7 | 21.63 | 12.22072 | 12.96506 | 1 |
| Dec 2028 | 11 | 24.97 | 10.65459 | 11.62668 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.86 | 0.60302 | 1.1417B | 7.53% | 599.6M |
| FQ2 2025 (Jun 2025) | 2.23 | 2.23 | 1.1735B | 17% | 1173.5M |
| FQ1 2025 (Mar 2025) | 2.38 | 2.38 | 1.195B | 19.9% | 1195M |
| FQ4 2024 (Dec 2024) | 1.88 | 1.88 | 1.1076B | 12.54% | 1107.6M |
| FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 1.0557B | 13.91% | 1055.7M |
| FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 0.974B | 6.8% | 974M |
| FQ1 2024 (Mar 2024) | 1.97 | 1.97 | 0.9572B | -3.24% | 957.2M |
| FQ4 2023 (Dec 2023) | 2.01 | 2.01 | 0.9687B | -3.72% | 968.7M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.41906
Consensus Revenue Estimates
0.563157681B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 2.5969 | -- | 2.5969 | 2.5969 | 8 |
| FQ3 2027 (Jul 2027) | 2.6137 | -- | 2.6137 | 2.6137 | 5 |
| FQ2 2027 (Jun 2027) | 2.6137 | -- | 2.55927 | 2.70528 | 8 |
| FQ1 2027 (Mar 2027) | 2.5509 | -- | 2.49778 | 2.64028 | 8 |
| FQ4 2026 (Oct 2026) | 2.45 | -- | 2.36196 | 2.57843 | 4 |
| FQ3 2026 (Jul 2026) | 2.46 | -16.26 | 2.3716 | 2.58895 | 4 |
| FQ2 2026 (Jun 2026) | 2.46296 | 9.46 | 2.41167 | 2.54926 | 8 |
| FQ1 2026 (Mar 2026) | 2.41906 | 1.61 | 2.36868 | 2.50382 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 1.42B | -- | 1.42B | 1.42B | 5 |
| FQ3 2027 (Jul 2027) | 1.38B | -- | 1.38B | 1.38B | 5 |
| FQ2 2027 (Jun 2027) | 1.37B | -- | 1.35B | 1.4B | 4 |
| FQ1 2027 (Mar 2027) | 1.33B | -- | 1.31B | 1.36B | 7 |
| FQ4 2026 (Oct 2026) | 0.56B | -- | 0.54B | 0.58B | 4 |
| FQ3 2026 (Jul 2026) | 0.56B | -105.34 | 0.54B | 0.58B | 4 |
| FQ2 2026 (Jun 2026) | 0.57B | -105.77 | 0.56B | 0.59B | 4 |
| FQ1 2026 (Mar 2026) | 0.56B | -112.2 | 0.55B | 0.58B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.25698 | 2.86 | 0.60302 | 21.08% |
| FQ2 2025 (Jun 2025) | 2.23 | 2.23 | 100% | |
| FQ1 2025 (Mar 2025) | 2.38 | 2.38 | 100% | |
| FQ4 2024 (Dec 2024) | 1.88 | 1.88 | 100% | |
| FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 100% | |
| FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 100% | |
| FQ1 2024 (Mar 2024) | 1.97 | 1.97 | 100% | |
| FQ4 2023 (Dec 2023) | 2.01 | 2.01 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.54B | $1.14B | $599.6M | 52.52% |
| FQ2 2025 (Jun 2025) | $0B | $1.17B | $1173.5M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.2B | $1195M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.11B | $1107.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.06B | $1055.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.97B | $974M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.96B | $957.2M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.97B | $968.7M | 100% |